74 results on '"Hoetzenecker K"'
Search Results
2. Clinical and prognostic implications of CD47 and PD-L1 expression in surgically resected small-cell lung cancer
3. Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study
4. Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466]
5. Clinical Ex Vivo Lung Perfusion—Pushing the Limits
6. (929) - Impact of Diaphragmatic Plication on Lung Function Parameters and Long-Term Outcomes After Lung Transplantation
7. (878) - Lungs from Donors with Chest Trauma Can Safely be Perfused on EVLP - and Used for Transplantation
8. (1421) - Feasibility Study of Bronchoalveolar Donor-Derived Cell Free DNA as Diagnostic Biomarker of Graft Health
9. (1270) - Evidence of Chronic Thromboembolic Disease During Ex Vivo Lung Perfusion of DBD Donor Lungs
10. (696) - The Impact of Preformed Donor-Specific Antibodies on Outcome After Lung Transplantation: A Retrospective Single-Center Experience
11. (684) - Comprehensive Characterization of Immune Cell Phenotypes in Lung Transplant Patients Receiving Belatacept
12. (685) - Development of an Easy-to-Use Flow Cytometric Panel for Monitoring B Regulatory Cells in Transplant Recipients
13. (625) - TTV Guided Belatacept Conversion After Lungtransplantation: Report of 7 Cases
14. (602) - Gene Expression Analysis of B and T Cells in De Novo mTOR Inhibitor Recipients Over Time
15. (55) - CD38 Antibody Daratumumab as an Add-On Rescue Therapy for AMR - First Report in Clinical Lung Transplantation
16. (52) - Transient versus Persistent Donor Specific Antibodies and Outcomes After Lung Transplantation
17. Thrombospondin‐1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes
18. (314) Lung Transplantation for Patients with a High-Risk Profile
19. (311) Lung Transplant in Patients with Suspicious Lung Nodules: A Single-Center Retrospective Data Analysis
20. (299) A Multicenter Experience with Extracorporeal Photopheresis as Treatment of Clad
21. (1274) Eight Micro-Rnas Show Differential Expression Twelve Months after Lung Transplantation: Preliminary Data from a High Throughput Technology
22. (1203) Unlike the US-LAS, the Eurotransplant-LAS is Not a Risk Factor for De-Novo Donor Specific Antibodies
23. (1186) Donor Derived Cell Free Dna after Lung Transplantation: Marker for Acute and Chronic Lung Allograft Injury?
24. (680) Effect of Combined Cytomegalovirus Prophylaxis on the Incidence of Cmv Infections, Clad and Survival after Lung Transplantation: Single-Center Experience of 1100 Patients
25. (114) Prophylactic Use of Extracorporeal Photopheresis (ecp) - A Prospective Randomized Single Center Trial
26. (110) Effect of Clad Phenotypes on the Outcome after Lung Retransplantation - A Retrospective Single Center Data Analysis
27. EP14.02-006 Subtype-specific Hypersensitivity to Oxidative Phosphorylation Inhibition in Small Cell Lung Cancer
28. EP14.02-003 Clinical Significance of MYC Family Members in Surgically Resected Limited-Stage Small Cell Lung Cancer: A Multicenter Study
29. EP14.02-002 Cisplatin in Combination with Entinostat exerts Synergistic Antineoplastic Activity in Small Cell Lung Cancer
30. Mechanisms of Action of Extracorporeal Photopheresis in the Control of BOS: Involvement of Circulating miRNAs
31. Gamma-Glutamyltransferase at the Time of Listing May Predict Irreversible Severe Cholangiopathy After Lung Transplantation for COVID19-ARDS
32. Short-Time Effect of Alemtuzumab Induction Therapy on B- and T-cell Subsets After Lung Transplantation
33. Contrary to Persisting De-Novo DSA, Transient De-Novo DSAs After Lung Transplantation Do Not Constitute a Risk Factor for Patient and Graft Survival
34. Erdheim-Chester Disease in a Patient after Double Lung Transplantation for Pulmonary Langerhans Cell Histiocytosis
35. International Experience with Lung Transplantation for COVID-19 Associated Acute Respiratory Distress Syndrome
36. Lung Transplantation for Acute Respiratory Distress Syndrome: A Multicenter Experience
37. Establishing the Hungarian Lung Transplantation Program How International Cooperation Can Help to Set up a New Program
38. Impact of Prone Positioning after Lung Transplantation - A Single Center Experience
39. Multi-Omics Correlations Reveal Lipid Species Involved in Lung Allograft Adaptation
40. Donor Ventilation Parameters as Predictors for Length of Mechanical Ventilation after Lung Transplantation: Results of a Prospective Multicenter Study
41. Baseline Lung Allograft Dysfunction after Lung Transplantation is Not Associated with Donor Factors
42. Requests for Exceptional LAS in Eurotransplant
43. Early Implementation of Renal Replacement Therapy after Lung Transplantation Does Not Impair Long-Term Kidney Function in iPAH Patients
44. P24.04 Outcome of Neoadjuvant or Adjuvant Radiotherapy in Multimodality Setting with EPP for Malignant Pleural Mesothelioma
45. Outcome of Extracorporeal Photopheresis as Add-On Therapy in Patients for Antibody-Mediated Rejection after Lung Transplantation
46. Bronchoalveolar Lavage Lipidomic Profiles Can Predict Short-Term Changes in Lung Function in Lung Transplant Recipients
47. Temporal Dynamics of the Pulmonary Microbiome after Lung Transplantation
48. Comprehensive Immunophenotypic Monitoring in a Prospective Randomized Controlled Trial of Prophylactic Use of Extracorporeal Photopheresis (ECP) in Lung Transplantation
49. Torque Teno Virus (TTV) Kinetics Can Predict Complications after Lung Transplantation
50. Liberal Use of Hemofiltration to Optimize Volume Status in iPAH Patients Does Not Impair Long-Term Kidney Function
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.